Related Funds
Fund Name | Location |
Arbitron | Columbia, Maryland, United States |
Atlas Special Opportunities | - |
Belfer Management | New York, New York, United States |
Founder Institute | California, Palo Alto, United States |
Fransabank | Beirut, Beirut Governorate, Lebanon |
Idodi Venture Capital | Barcelona, Catalonia, Spain |
Inktomi Corporation | California, Foster City, United States |
InSite | California, Redondo Beach, United States |
Lanzhe Capital | - |
Markpoint Venture Partners | Allen, Texas, United States |
New Tranx Information Technology | Beijing, Beijing, China |
Old Kent Road (OKR) Financial | Alberta, Calgary, Canada |
ORAMA | Brazil, Rio de Janeiro, Rio De Janeiro |
Otter Rock Capital | California, Los Angeles, United States |
Primary Venture Partners | New York, New York, United States |
Qingdao Liangqi Jiaoyu Fazhan Youxian Gongsi | China, Qingdao Shi, Shandong |
The Graduate Syndicate | Boston, Massachusetts, United States |
Third Point Ventures | New York, New York, United States |
TIF Ventures Pte | California, Redwood City, United States |
Trust Ventures | Austin, Texas, United States |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
SN BioScience | $609K | 02 Jul 2020 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
Yast | $40K | 10 Jan 2010 | Vestfold og Telemark |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
SN BioScience | $609K | 02 Jul 2020 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
Yast | $40K | 10 Jan 2010 | Vestfold og Telemark |